SeqLL (NASDAQ:SQL) Shares Down 20.2%

Shares of SeqLL Inc. (NASDAQ:SQLGet Free Report) fell 20.2% on Monday . The company traded as low as $6.60 and last traded at $6.60. 22,000 shares traded hands during trading, a decline of 58% from the average session volume of 52,119 shares. The stock had previously closed at $8.27.

SeqLL Trading Down 20.2 %

The business’s 50-day simple moving average is $4.11 and its two-hundred day simple moving average is $6.84. The company has a debt-to-equity ratio of 0.50, a current ratio of 5.04 and a quick ratio of 5.04. The stock has a market capitalization of $2.51 million, a price-to-earnings ratio of -0.40 and a beta of 1.34.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in SeqLL stock. Renaissance Technologies LLC purchased a new stake in SeqLL Inc. (NASDAQ:SQLFree Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 183,400 shares of the company’s stock, valued at approximately $73,000. Renaissance Technologies LLC owned approximately 1.32% of SeqLL at the end of the most recent reporting period. 1.82% of the stock is currently owned by hedge funds and other institutional investors.

About SeqLL

(Get Free Report)

SeqLL Inc operates as a life sciences instrumentation and research services company worldwide. It focus on development of scientific assets and novel intellectual property across multiple omics fields. The company's True Single Molecule Sequencing technology (tSMS) platform offers a single molecule solution for DNA and RNA sequencing through detection of nucleic acids to researchers for analyzing many billions of single molecules in a single experiment and generate accurate and reproducible data.

Read More

Receive News & Ratings for SeqLL Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SeqLL and related companies with MarketBeat.com's FREE daily email newsletter.